What could be prescribed for a patient with 7 days unsettled fever with Amoxiclav tablet and we have limited antibiotics
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
"typhoid fever" AND treatment
Searching the Web
fever unresponsive to amoxicillin-clavulanate 7 days empirical antibiotic choice resource limited setting
Reading File
Fever for 7 days despite amoxicillin-clavulanate: what this means and next steps
Why amoxiclav may be failing: Amoxicillin-clavulanate does not reliably cover several common causes of persistent ("step-ladder" or unremitting) fever, and organisms causing it may simply be resistant. In an endemic setting the leading possibilities to consider are:
- Enteric fever (typhoid/paratyphoid) - amoxicillin/ampicillin-class drugs are no longer considered reliable first-line therapy because of widespread resistance (Park's Textbook of Preventive and Social Medicine, p. 1718; Red Book 2021, p. 1724 - notes extensively drug-resistant S. Typhi strains susceptible only to azithromycin and carbapenems).
- Malaria, dengue, rickettsial illness, or a viral fever - none of these respond to any antibiotic, so ruling them out (rapid malaria test/blood smear, dengue NS1, basic CBC) is essential before adding another drug.
- Atypical pneumonia (Mycoplasma), UTI/pyelonephritis with a resistant organism, or an abscess - each needs a different agent than amoxiclav covers.
If clinical picture fits enteric fever (gradual-onset fever, relative bradycardia, coated tongue, abdominal discomfort, hepatosplenomegaly) and antibiotic stock is limited
Azithromycin is the most practical single agent when supplies are limited, because it is oral, once-daily, well tolerated, cheap, and remains effective even against fluoroquinolone-resistant and many multidrug-resistant S. Typhi strains:
- Azithromycin 500 mg once daily x 5-7 days (or 10-20 mg/kg/day in children) - per Sleisenger and Fordtran's Gastrointestinal and Liver Disease (p. 612-620) and Tintinalli's Emergency Medicine (p. 3384-3387). A 2024 systematic review of RCTs (Uzair et al., J Ayub Med Coll [PMID: 39623850]) found oral azithromycin has clinical efficacy comparable to fluoroquinolones and ceftriaxone across age groups, supporting it as a reasonable stewardship-friendly choice.
Alternatives if azithromycin is unavailable or the strain is known/likely fully sensitive:
- Ciprofloxacin 500 mg twice daily (or levofloxacin 500 mg once daily) x 5-7 days - but fluoroquinolone resistance is now high in South Asia, so this is a weaker empirical choice there.
- Cefixime (oral 3rd-generation cephalosporin) 15-20 mg/kg/day x 7-14 days - a good oral option where injectables aren't available.
- Ceftriaxone 1-2 g IV/IM daily x 7-14 days - reserve for toxic-looking patients, suspected complications, or if oral options fail; needs injection capacity.
Before escalating, do these quick checks (cheap and fast even with limited resources)
- Malaria RDT/smear and dengue NS1 - if either positive, stop chasing antibiotics.
- Basic exam for a localizing focus (chest, urine, skin, abdomen) that would point to a different, more targeted drug.
- Red flags needing referral/hospital rather than another oral course at a clinic: persistent high fever with hypotension, altered mental status, severe abdominal pain/rigidity (possible perforation), GI bleeding, pregnancy, or infancy.
Bottom line
Given limited antibiotic stock and a 7-day fever unresponsive to amoxiclav in an endemic setting, empirical azithromycin is the most defensible next step for suspected enteric fever - effective, resistance-forgiving, oral, and easy to stock in limited quantities. Confirm with blood culture where possible, and rule out malaria/dengue first since no antibiotic will help those. This is general clinical guidance, not a substitute for an in-person assessment with labs; if the patient looks unwell or has any red-flag feature, refer for hospital-level care rather than trialing another oral course.
Give me the normal Complete blood count values and limits knowledge chart for pediatric patients of different age groups
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Pediatric Complete Blood Count (CBC) Reference Chart by Age
Normal CBC values change significantly across childhood - hemoglobin/hematocrit are highest at birth and fall to a physiologic nadir around 2 months, while lymphocytes predominate over neutrophils in early childhood before reverting to the adult pattern near puberty. Below is a consolidated reference chart drawn from standard pediatric hematology tables (Harriet Lane Handbook, Tietz Textbook of Laboratory Medicine) supplemented with widely-used Nelson Textbook of Pediatrics / Nathan-Oski hematology norms.
Hemoglobin (Hb) and Hematocrit (Hct)
| Age | Hemoglobin (g/dL) | Hematocrit (%) |
|---|---|---|
| Cord blood (term) | 13.5-19.5 | 42-60 |
| Day 1-3 (birth, capillary) | 14.5-22.5 | 45-67 |
| 2 weeks | 12.5-20.5 | 39-63 |
| 1 month | 10.0-18.0 | 31-55 |
| 2 months (physiologic nadir) | 9.0-14.0 | 28-42 |
| 3-6 months | 9.5-14.5 | 29-42 |
| 6 months-1 year | 10.5-13.5 | 33-39 |
| 1-3 years | 10.5-13.5 | 31-39 |
| 4-13 years | 11.5-15.5 | 34-43 |
| 14-20 years, male | 12.0-16.5 | 39-50 |
| 14-20 years, female | 11.5-15.0 | 35-45 |
(Hct 0-11 mo: 28-39%; 1-3 y: 31-39%; 4-13 y: 34-43%; 14-20 y M: 39-50%; 14-20 y F: 35-45% - Tietz Textbook of Laboratory Medicine, Table A-4)
White Blood Cell (WBC) Count
| Age | Total WBC (x10³/μL) |
|---|---|
| Birth | 9.0-30.0 |
| 24 hours | 9.4-34.0 |
| 1 month | 5.0-19.5 |
| 6 months-1 year | 6.0-17.5 |
| 0-2 years | 5.75-13.5 |
| 3-4 years | 4.9-11.8 |
| 5-20 years | 4.2-10.0 |
(0-2 y: 5.75-13.5; 3-4 y: 4.92-11.8; 5-20 y: 4.23-9.99 x10³/μL - Tietz Textbook of Laboratory Medicine, Table A-4)
WBC Differential (approximate % of total, key ages)
| Age | Neutrophils (%) | Lymphocytes (%) | Monocytes (%) | Eosinophils (%) | Basophils (%) |
|---|---|---|---|---|---|
| Birth | 50-60 | 25-35 | 5-8 | 1-3 | 0-1 |
| 1-2 weeks | 30-40 | 40-50 | 5-8 | 1-3 | 0-1 |
| 6 months-6 years | 30-40 | 45-60 (lymphocyte-predominant) | 5-8 | 1-3 | 0-1 |
| >6-8 years onward | 50-60 | 30-40 (reverts to adult pattern) | 4-6 | 1-3 | 0-1 |
(Basophils reference range 0.0-0.1 x10³/μL across 0-20 y - Tietz Textbook of Laboratory Medicine, Table A-4)
Note: children under about 4-6 years normally have a lymphocyte-predominant differential (a relative lymphocytosis), which reverses to the adult neutrophil-predominant pattern by later childhood/adolescence. This is a normal physiologic feature, not a marker of infection, in young children.
Red Blood Cell (RBC) Count
| Age | RBC (x10⁶/μL) |
|---|---|
| Birth | 4.1-6.1 |
| 1 month | 3.0-5.4 |
| 6 months-2 years | 3.7-5.3 |
| 2-6 years | 3.9-5.3 |
| 6-12 years | 4.0-5.2 |
| 12-18 years, male | 4.5-5.3 |
| 12-18 years, female | 4.1-5.1 |
Platelet Count
| Age | Platelets (x10³/μL) |
|---|---|
| Birth | 150-450 |
| Infancy through childhood | 150-450 (relatively stable across all pediatric ages) |
| Adolescence | 150-450 |
Platelet counts are notable for being fairly constant across all pediatric age groups compared to Hb/Hct and WBC, which show more age-dependent variation.
Key Clinical Points
- Hemoglobin/Hct peak at birth (polycythemia of the newborn is physiologic), fall to a nadir around 6-9 weeks of life (physiologic anemia of infancy, related to the switch from fetal to adult erythropoiesis), then rise gradually through childhood to adult levels at puberty (with sex divergence appearing after ~12-14 years due to androgen effects on erythropoiesis).
- WBC count is highest in the neonatal period and gradually declines toward adult ranges through childhood.
- Lymphocyte-predominant differential in infants and young children is a normal finding and should not be mistaken for viral infection or leukemia without other supporting features.
- Values vary somewhat by analyzer/instrument and reference laboratory (Tietz table shows slightly different cutoffs between Sysmex and Beckman Coulter platforms) - always interpret against your local lab's stated reference range when available, since these are guideline ranges rather than universal absolutes.
Sources: Tietz Textbook of Laboratory Medicine, 7th Ed., Table A-4 (Pediatric and Adult Reference Intervals for Hematologic Markers); The Harriet Lane Handbook, 23rd Ed. (pediatric hematology reference tables); standard pediatric hematology norms consistent with Nelson Textbook of Pediatrics and Nathan & Oski's Hematology of Infancy and Childhood.
If you want, I can build this into a printable PDF or spreadsheet chart for clinical reference - let me know the preferred format.
This is a shared conversation. Sign in to Orris to start your own chat.